HYPERALDOSTERONISM side effect
What is HYPERALDOSTERONISM ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
HYPERALDOSTERONISM and Recently Reported Side Effects
HYPERALDOSTERONISM and 15 most Active Side Effect polls
HYPERALDOSTERONISM and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Trileptal Side Effects Report #5773340-1
Physician from BELGIUM reported TRILEPTAL problem on June 04, 2008. Female patient was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyperaldosteronism, hyponatraemia, . TRILEPTAL dosage: 600 MG, BID. During the same period patient was treated with KEPPRA, FEMOSTON. Patient recovered.
Actonel Side Effects Report #5656208-0
ACTONEL problem was reported by a Physician from JAPAN on Feb 25, 2008. Female patient, 80 years of age, was diagnosed with osteoporosis and was treated with ACTONEL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, hyperaldosteronism, liver disorder, . ACTONEL dosage: 17.5 MG ONCE WEEKLY, ORAL. During the same period patient was treated with SHAKUYAKUKANZOUTOU. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5314377-6
Health Professional from SWITZERLAND reported VALSARTAN problem on Apr 23, 2007. Male patient, 44 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: adrenal adenoma, hyperaldosteronism, hypertension, retinopathy, ventricular hypertrophy, . VALSARTAN dosage: unknown. During the same period patient was treated with CARVEDILOL, HYDROCHLOROTHIAZIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5322125-9
VALSARTAN problem was reported by a Health Professional from SWITZERLAND on May 03, 2007. Male patient, 44 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: adrenal adenoma, blood aldosterone increased, hyperaldosteronism, hypertension, primary hyperaldosteronism, renin increased, retinopathy, ventricular hypertrophy, . VALSARTAN dosage: unknown. During the same period patient was treated with CARVEDILOL, HYDROCHLOROTHIAZIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.